IGLC2 and neoplasm: Importantly, tumor cells in HER2neg TNBC seemed more likely to be associated with activities involving immune responses, highly expressing immunoglobulin-related genes (such as IGKC, IGHG1, IGHG4 and IGLC2) which are associated with the favorable prognosis and have been verified in the clinical TNBC cases.